Compare The Coca-Cola Co K (KO) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
The Coca-Cola Co K vs Tenet Healthcare Corporation — how do they compare? The Coca-Cola Co K trades at $81.81 (market cap $353.32B), while Tenet Healthcare Corporation trades at $196.95 (market cap $16.74B). The key difference: The Coca-Cola Co K is far larger — about 21.1× Tenet Healthcare Corporation's market cap, and The Coca-Cola Co K pays a 2.58% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| KO | THC | |
|---|---|---|
Market Cap | $353.32B | $16.74B |
Volume | 14,630,257 | — |
Sector | Consumer Staples | Health |
52-Week High | $84.92 | $244.80 |
52-Week Low | $65.67 | $148.38 |
Enterprise Value | $383.39B | $26.99B |
Dividend Yield | 2.58% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Coca-Cola (KO) trades at $81.74, up 0.22% today, with a bearish technical signal but strong fundamentals including 27.8% net margin and consistent earnings beats. The stock shows robust profitability with ROE at 45.8% and positive cash flow trends, supported by a $0.53 quarterly dividend. Recent news highlights institutional buying and stable demand ahead of Q2 2026 earnings.
Outlook remains positive with a $90.67 consensus price target implying 11% upside, though risks include regional demand divergence and high debt. Analyst sentiment is bullish (60% Buy), but technical resistance near $83 may limit near-term gains. Long-term investors may find value in KO's dividend stability and brand strength.
Tenet Healthcare (THC) trades at $194.38, down 0.27% on the day, with a neutral technical signal despite strong fundamental performance. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $4.82 exceeding expectations of $4.17. Valuation metrics appear attractive with a P/E of 10.14 and P/S of 0.79, while profitability remains robust with 82.47% gross margins and 37.87% ROE. Recent news highlights the company's expanding outpatient footprint through USPI as a key growth driver.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and a $235.88 price target representing 21% upside potential. The company's solid earnings momentum and defensive healthcare positioning during market volatility provide stability. Key risks include execution challenges in outpatient expansion and potential regulatory headwinds affecting hospital operations. Cash flow trends show improvement with projected net cash flow narrowing from -$136M in 2025 to -$32M in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
